Abstract
Ovarian germ cell tumors are rare malignancies that occur in young women. Histologically they are classified as dysgerminoma, yolk sac tumor, embryonal carcinoma, polyembryoma, nongestational choriocarcinoma, and teratomas and mixed cell tumors. Due to the development of cisplatin-based chemotherapy, virtually all patients with early-stage, completely resected ovarian germ cell tumors will survive after careful surgical staging and three courses of adjuvant bleomycin, etoposide, and cisplatin. Furthermore, 70-80% of patients with incompletely resected or advanced tumors will be long-term survivors. Acute toxicity of treatment is relatively modest. Late consequences of chemotherapy are limited. Efforts should concentrate on fertility preservation for patients who desire subsequent pregnancies.
| Original language | English (US) |
|---|---|
| Title of host publication | Textbook of Uncommon Cancer |
| Publisher | Wiley |
| Pages | 519-530 |
| Number of pages | 12 |
| ISBN (Print) | 9781118083734 |
| DOIs | |
| State | Published - Sep 20 2012 |
Keywords
- Chemotherapy
- Dysgerminoma
- Malignant tumors
- Nondysgerminomatous ovarian germ cell tumors
- OGCT
- Radiation therapy
- Residual/recurrent disease
- Small cell carcinoma
- Yolk sac tumor
ASJC Scopus subject areas
- General Medicine
Divisions
- Medical Oncology
Fingerprint
Dive into the research topics of 'Germ Cell Tumors of the Ovary'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS